Pharma-Bio Serv Statistics
Total Valuation
Pharma-Bio Serv has a market cap or net worth of 11.45 million. The enterprise value is 2.87 million.
| Market Cap | 11.45M |
| Enterprise Value | 2.87M |
Important Dates
The next estimated earnings date is Friday, January 29, 2027.
| Earnings Date | Jan 29, 2027 |
| Ex-Dividend Date | Feb 27, 2026 |
Share Statistics
Pharma-Bio Serv has 22.90 million shares outstanding. The number of shares has decreased by -0.13% in one year.
| Current Share Class | 22.90M |
| Shares Outstanding | 22.90M |
| Shares Change (YoY) | -0.13% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 54.80% |
| Owned by Institutions (%) | 1.49% |
| Float | 8.41M |
Valuation Ratios
The trailing PE ratio is 45.55 and the forward PE ratio is 5.00.
| PE Ratio | 45.55 |
| Forward PE | 5.00 |
| PS Ratio | 1.21 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 11.43 |
| EV / Sales | 0.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.30
| Current Ratio | 11.30 |
| Quick Ratio | 11.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.25% and return on invested capital (ROIC) is -7.53%.
| Return on Equity (ROE) | 2.25% |
| Return on Assets (ROA) | -0.77% |
| Return on Invested Capital (ROIC) | -7.53% |
| Return on Capital Employed (ROCE) | -1.48% |
| Weighted Average Cost of Capital (WACC) | 8.27% |
| Revenue Per Employee | 172,429 |
| Profits Per Employee | 4,573 |
| Employee Count | 55 |
| Asset Turnover | 0.76 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Pharma-Bio Serv has paid 17,474 in taxes.
| Income Tax | 17,474 |
| Effective Tax Rate | 6.50% |
Stock Price Statistics
The stock price has decreased by -25.37% in the last 52 weeks. The beta is 0.73, so Pharma-Bio Serv's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -25.37% |
| 50-Day Moving Average | 0.51 |
| 200-Day Moving Average | 0.54 |
| Relative Strength Index (RSI) | 51.21 |
| Average Volume (20 Days) | 8,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, Pharma-Bio Serv had revenue of 9.48 million and earned 251,525 in profits. Earnings per share was 0.01.
| Revenue | 9.48M |
| Gross Profit | 3.07M |
| Operating Income | -154,943 |
| Pretax Income | 268,999 |
| Net Income | 251,525 |
| EBITDA | -97,005 |
| EBIT | -154,943 |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 8.58 million in cash and no debt, with a net cash position of 8.58 million or 0.37 per share.
| Cash & Cash Equivalents | 8.58M |
| Total Debt | n/a |
| Net Cash | 8.58M |
| Net Cash Per Share | 0.37 |
| Equity (Book Value) | 10.44M |
| Book Value Per Share | 0.46 |
| Working Capital | 10.24M |
Cash Flow
In the last 12 months, operating cash flow was -414,892 and capital expenditures -6,472, giving a free cash flow of -421,364.
| Operating Cash Flow | -414,892 |
| Capital Expenditures | -6,472 |
| Depreciation & Amortization | 57,938 |
| Net Borrowing | n/a |
| Free Cash Flow | -421,364 |
| FCF Per Share | -0.02 |
Margins
Gross margin is 32.32%, with operating and profit margins of -1.63% and 2.65%.
| Gross Margin | 32.32% |
| Operating Margin | -1.63% |
| Pretax Margin | 2.84% |
| Profit Margin | 2.65% |
| EBITDA Margin | -1.02% |
| EBIT Margin | -1.63% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 15.00%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 15.00% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 682.89% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.13% |
| Shareholder Yield | 15.13% |
| Earnings Yield | 2.20% |
| FCF Yield | -3.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pharma-Bio Serv has an Altman Z-Score of 10.76 and a Piotroski F-Score of 4.
| Altman Z-Score | 10.76 |
| Piotroski F-Score | 4 |